Abstract:Objective To investigate the mild traumatic brain injury (mTBI) using diffusion tensor imaging (DTI)in MRI and the serum neuron specific enolase (NSE) and S100B protein expression changes.Methods A total of 84 patients with mild injury and 70 age and sex matched normal volunteers as controls were prospectively admitted to Department of Neurosurgery,Tianjin First Center Hospital between October 2013 and January 2016.All participants underwent Rivermead post-concussion symptoms questionnaire (RPQ) within 7 days of laboratory examination and evaluation.Among them,all patients with mTBI and 50 normal volunteers were included in this study to undergo MRI scanning,including susceptibility weighted imaging (SWI) and diffusion tensor imaging (DTI),within 7 days to compare the imaging characteristics.The patients were divided into 2 groups depending on SWI appearances.The mTBI group 1 consisted of those with positive findings in SWI and the mTBI group 2 consisted of the other patients.The differences in RPQ scores and DTI data,including fractional anisotropy (FA) and apparent diffusion coefficient (ADC),was analyzed between those 2 groups.The expression levels of serum NSE and S100B protein in the 34 patients with mTBI and 20 normal volunteers.Results Among the 84 patients,there were 31 patients with abnormal SWI at admission and 53 patients with normal SWI,and their median RPQ scores were 17 (1-31) and 15 (22-27) respectively.There was no significant difference between the 2 groups (P =0.116).At 6 months post discharge,20 cases in abnormal SWI group and 33 cases in normal SWI group were followed up,and their RPQ scores were 6 (1-15) and 3 (1-11) respectively(P =0.177).DTI analysis showed that there were 32 abnormal FA areas in SWI abnormal group and 7 in SWI normal group.In addition,there were 34 ADC abnormal areas in SWI abnormal group and 7 in SWI normal group.Those differences were statistically significant (P =0.001,P ＜0.001).Serum NSE levels were 10.01 ±2.82 μg/ L,30.51 ± 12.32 and 12.35 ± 3.67 μg/L,S100B protein levels were 0.17 ± 0.06 μg/L,0.52 ± 0.26 μg/L and 0.19 ±0.01 μg/L in healthy control group,abnormal SWI group and normal SWI group,respectively.There were significant differences in NSE and S100B protein levels among the 3 groups (P =0.006,P =0.025),while there was no significant difference between the healthy control group and the normal SWI group (all P ＞ 0.05).Conclusion The combined detection of serum NSE and S100B protein by cranial DTI may have important clinical value and significance in accurate diagnosis and treatment of acute mTBI.

Relationship between cerebrospinal fluidα-Synuclein and prognosis of patients with traumatic brain injury

High S100B Levels in Cerebrospinal Fluid and Peripheral Blood of Patients with Acute Basal Ganglial Hemorrhage Are Associated with Poor Outcome.

Serum Albumin And Prealbumin Predict The Poor Outcome Of Traumatic Brain Injury

Lactic Acid, Neuron-Specific Enolase, and Blood-Brain Barrier Index after a Severe Traumatic Brain Injury: a Prospective Study

Change of Concentrations of Serum Cyclophilin A in Patients with Traumatic Brain Injury and its Clinical Significance

Clinical Evaluation of Prognosis of Severe Posttraumatic Brain Injuries by Using S-100B

Role of Diffusion Tensor Imaging Combined with Neuron-Specific Enolase and S100 Calcium-binding Protein B Detection in Predicting the Prognosis of Moderate and Severe Traumatic Brain Injury

Dynamic Changes of Serum Glial Fibrillary Acidic Protein Content in Patients with Brain Injury and Their Cllnical Significance

Relationship study between serum brain red protein content and the de-gree of nerve injury in patients with brain injury

Dynamic Change of Cerebrospinal Fluid Endostatin in Patients with Severe Traumatic Brain Injury and Its Clinical Significance

Changes of serum cortisol in traumatic brain injury

Serum Neuron Specific Enolase and Matrix Metalloproteinases in Patients with Severe Traumatic Brain Injury and the Clinical Significance

Role of Α-Ii-spectrin Breakdown Products in the Prediction of the Severity and Clinical Outcome of Acute Traumatic Brain Injury.

Changes in the levels of serum glial fibrillary acidic protein and the correlation with outcomes in severe traumatic brain injury patients

The roles of diffusion tensor imaging and serum biochemical indexes in the evaluation of acute mild traumatic brain injury

Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury

Dynamic changes of angioteusin II、Interleukin-6 in the blood of the patient with isolated traumatic brain injury

Changes of NLRP3 in serum and cerebrospinal fluid of patients after moderate to severe traumatic brain injury and their predictive values for prognosis

Study on Serum Mir-185-5p in Assessing the Injury Severity and Prognosis of Patients with Traumatic Brain Injury.

Expression of heat shock protein 70 and Annexin A1 in serum of patients with acutely severe traumatic brain injury

Serum calprotectin as a prognostic predictor in severe traumatic brain injury